CSIMarket
 


Quidelortho Corp  (QDEL)
Other Ticker:  
 


Quidelortho's Pre-Tax Profit Margin by quarter

Trends, Rankings, Statistics



QDEL Pre-Tax Profit Margin (Jul 03 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
Y / Y Revenue Change 247.32 % 167.03 % -21.3 % 7.07 % -12.46 %
Seq. Revenue Change -38.8 % 57.37 % 24.94 % 188.62 % -52.95 %
Revenue In Millions $613.40 $1,002.26 $636.87 $509.74 $176.61
Pre-Tax Profit Margin 6.99 % 61.92 % 58.94 % 55.22 % 12.28 %
Pre-Tax Profit Margin Total Ranking # 1977 # 213 # 290 # 280 # 1668
Pre-Tax Income In Millions $42.90 $620.63 $375.38 $281.49 $21.68
Y / Y Pre-Tax Income Change 97.85 % 179.81 % -39.02 % -4.83 % -72.96 %
Seq. Pre-Tax Income Change -93.09 % 65.34 % 33.35 % 1198.22 % -90.22 %


Commenting Second Quarter 2022 Pre-Tax Profit Margin
Quidelortho Corp experienced contraction in Pre-Tax Income by -93.09 % to $613 millions and Revenue by -38.8 %, while Pre-Tax Profit Margin fell to 6.99 %, below company's average Pre-Tax Profit Margin.

Observing second quarter 2022 results within In Vitro & In Vivo Diagnostic Substances industry 3 other companies have achieved higher Pre-Tax Profit Margin. While Pre-Tax Profit Margin overall ranking has deteriorated compare to previous quarter from 213 to 1977.

QDEL's Pre-Tax Profit Margin second quarter 2022 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 4
Healthcare Sector # 134
Overall # 1977

Pre-Tax Profit Margin Statistics
High Average Low
76.07 % 28.02 % 0.21 %
(Dec 31 2020)   (Mar 31 2012)




Other Pre-Tax Profit Margin Profitability Ratios
QDEL's Cumulative Pre-Tax Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Pre-Tax Profit Margin Trends and Statistics
Healthcare Sector Pre-Tax Profit Margin Statistics
Pre-Tax Profit Margin Profitability Trends for overall market
QDEL's Pre-Tax Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Pre-Tax Profit Margin
Lowest Ranking Pre-Tax Profit Margin
Pre-Tax Profit Margin Profit Margin for QDEL's Competitors
Pre-Tax Profit Margin Profit Margin for Quidelortho's Suppliers
Pre-Tax Profit Margin Profit Margin for QDEL's Customers

You may also want to know
QDEL's Annual Growth Rates QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roe QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Pre-Tax Income Growth
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Comparisons


Companies with similar Pre-Tax Profit Margin in the quarter ending Jul 03 2022, within In Vitro & In Vivo Diagnostic Substances Industry Pre-Tax Profit MarginJul 03 2022 MRQ Pre-Tax IncomeJul 03 2022 MRQ Revenue
Neogen Corporation  13.50 %$ 18.909 $ 140.093 
Quidelortho Corp  6.99 %$ 42.900 $ 613.400 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WULF's Profile

Stock Price

WULF's Financials

Business Description

Fundamentals

Charts & Quotes

WULF's News

Suppliers

WULF's Competitors

Customers & Markets

Economic Indicators

WULF's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071